Canakinumab is a monoclonal antibody targeting interleukin-1β (IL-1β), which is mainly used to treat a variety of autoinflammatory diseases and gout attacks. This article will comprehensively introduce the relevant information of canakinumab from three aspects: medication guide, drug purchase guide and patient dietary guide, to help patients and medical staff better understand and use this drug.
Canakinumab Medication Guide
Canakinumab is an important biological agent that is suitable for the treatment of a variety of autoinflammatory diseases. Proper use of canakinumab can effectively control disease symptoms and improve the quality of life of patients.
Indications and Usage and Dosage
Canakinumab is mainly used to treat periodic fever syndromes (such as CAPS, TRAPS, HIDS/MKD, FMF), Still's disease (including AOSD and SJIA) and gout attacks. The specific usage and dosage should be adjusted according to the patient's weight and disease type. For example, when the weight of CAPS patients exceeds 40kg, the recommended dose is 150mg subcutaneous injection once every 8 weeks; for children weighing between 15-40kg, the dose is 2mg/kg once every 8 weeks.
Adverse reactions and precautions
Common adverse reactions include nasopharyngitis, injection site reactions, upper respiratory tract infections, etc. When using canakinumab, special attention should be paid to the risk of serious infection and avoid combined use with TNF inhibitors. Live vaccines should be avoided during treatment, and all recommended vaccinations should be completed before medication.
The correct use of canakinumab requires strict compliance with doctor's orders, regular monitoring of efficacy and adverse reactions to clarify the safety of treatment.
Canakinumab purchase guide
Canakinumab is not currently available in China, and patients need to purchase original drugs through specific channels. Understanding drug purchase information can help patients better plan treatment.
Manufacturer and specifications
Canakinumab is produced by Novartis, Switzerland, with a specification of 150mg/mL and a price of approximately US$1,331 per box. There are no generic drugs on the market, and patients need to purchase original drugs through formal channels.
Medical insurance and drug purchase channels
Canakinumab is not included in China's medical insurance, and patients need to purchase it at their own expense. When purchasing drugs, you need to choose a reliable medical institution or pharmacy to avoid purchasing counterfeit and inferior products.
During the drug purchase process, patients should fully understand the source and price of the drug, and clarify the safety and economy of the drug.
Dietary guide for canakinumab patients
A reasonable diet can assist the therapeutic effect of canakinumab and reduce the occurrence of adverse reactions.
Dietary recommendations
Patients should maintain a balanced diet and consume more foods rich in protein, vitamins and minerals, such as lean meat, fish, fresh vegetables and fruits. Avoid high-fat, high-sugar and high-salt diets to reduce inflammatory responses.
Taboo foods
During treatment, avoid eating foods that may cause allergies or aggravate inflammation, such as spicy foods, alcohol and processed foods. At the same time, pay attention to dietary hygiene and prevent infection.
Scientific eating habits can help improve the efficacy of canakinumab and help patients better manage the disease.
